Skip to main content

Table 2 Calculated Combination Indexes for human breast cancer (MDA-MB-231) cells treated with paclitaxel, doxorubicin or cyclophosphamide in combination with TTFields.

From: Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields)

  Combination index
  MDA-MB-231 cells
TTFields intensity
(V/cm)
Paclitaxel Doxorubicin Cyclophosphamide
  CI40 CI50 CI50
0.625 - - 0.74
1.25 0.97 0.99 0.84
1.75 0.86 0.98 0.95